Differential involvement of mitochondrial dysfunction, cytochrome P450 activity, and active transport in the toxicity of structurally related NSAIDs.
In conclusion, we demonstrate the use of yeast to investigate the mechanisms underlying the toxicity of structurally related drugs. PMID: 22138569 [PubMed - as supplied by publisher] (Source: Toxicology in Vitro)

Safety of ketorolac in surgical neonates and infants 0 to 3 months old
Conclusions: Infants younger than 21 days and less than 37 weeks CGA are at significantly increased risk for bleeding events and should not be candidates for ketorolac therapy. (Source: Journal of Pediatric Surgery)div id=medwormpbiMedWorm Message:/i/b Please have a look at this new site driven by MedWorm: a href=http://www.thebreastcancerdaily.com/ target=_blankThe Breast Cancer Daily/a/p/div